Lifesaving new drug offers hope to 7,000 Britons a year who suffer a dangerous form of heart strain

Mavacamten - also known as Camzyos - is the first medicine developed specifically to tackle obstructive hypertrophic cardiomyopathy, a serious disorder that affects about 7,000 people in the UK.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news